Navigation Links
Hormone-Boosting Drug May Help Treat Frailty
Date:1/27/2009

Older adults who took capromorelin had boost in lean body mass

TUESDAY, Jan. 27 (HealthDay News) -- A drug designed to increase the body's production of growth hormone may help treat frailty in older adults, a new study shows.

Older adults have greatly reduced production of growth hormone, which regulates metabolism and helps build muscle mass. Age-related decreases in strength and physical agility can led to disability and loss of independence.

"By boosting the production of growth hormones, we may be able to slow this process and help people lead active lives longer," study first author Dr. Heidi K. White, an associate professor of medicine at Duke University Medical Center, said in a Duke news release.

The study included 395 women and men, aged 65 to 84, with mild physical function limitations. They were randomly selected to take either a placebo or one of four doses of the investigational drug capromorelin. All four doses of the drug increased growth hormone production, and the findings were sustained over one year of treatment.

The researchers also found that participants who took the drug showed a significant increase in lean body mass (1.4 kilograms vs. 0.3 kg for placebo) and improvements in two physical function tests -- tandem walking (heel to toe) and stair climbing. Fatigue, insomnia and small increases in fasting glucose and HbA1c scores were among the side effects noted among those who took the drug.

The findings were released online and were expected to be published in the April issue of The Journal of Clinical Endocrinology & Metabolism. The study was funded by Pfizer, which developed capromorelin.

While the results suggest that stimulating growth hormone production can increase the body's ability to develop lean muscle, the physical improvements seen in the study were relatively mild.

For example, the patients who took the drug showed a 7 percent increase in their ability to climb stairs. A previous study found that a home-based exercise program among a similar patient population achieved a 23 percent to 24 percent improvement in stair-climbing ability after 10 weeks.

"Following further investigation, capromorelin could be used in combination with exercise," White suggested.

More information

The AGS Foundation for Health in Aging has more about physical activity.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Jan. 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
5. Free distribution of insecticide-treated mosquito nets can save lives
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone-Boosting Drug May Help Treat Frailty 
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: